Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 11,709Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Dr. Reddy's Laboratories

02 1Breckenridge Pharmaceutical

03 2NanoAlvand

04 2Ajanta Pharma Limited

05 2Annora Pharma

06 2Auro Pharma Inc

07 2Aurobindo Pharma Limited

08 2Biocon

09 2Bluepharma

10 3DelNova Healthcare

11 2Devatis AG

12 2Dexcel Pharma

13 1Hikma Pharmaceuticals

14 2Intas Pharmaceuticals

15 1JAMP PHARMA

16 2Laboratorio Eczane Pharma

17 2MSN Laboratories

18 1Micro Labs Limited

19 15Pfizer Consumer Healthcare

20 15Pfizer Inc

21 1Pharmascience Inc.

22 3Pluviaendo

23 1Prinston

24 2Pulse Pharmaceuticals

25 4Sandoz B2B

26 1Sinotherapeutics

27 3Taro Pharmaceutical Industries

28 1Unichem Laboratories Limited

29 2Yaopharma

30 3Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Tofacitinib Citrate

Brand Name :

Dosage Form : Oral Solid Dosage Form

Dosage Strength : 22MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Dr Reddy Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Tofacitinib Citrate

Brand Name : Rhofanib

Dosage Form : Film Coated Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Tofacitinib Citrate

Brand Name : Rhofanib

Dosage Form : Film Coated Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

05

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2021-06-01

Application Number : 212943

Regulatory Info : DISCN

Registration Country : USA

blank

06

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

TOFACITINIB

Brand Name : TOFACITINIB

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 215356

Regulatory Info :

Registration Country : USA

blank

07

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : SOLUTION;ORAL

Dosage Strength : EQ 1MG BASE/ML

Packaging :

Approval Date : 2023-09-25

Application Number : 216878

Regulatory Info : DISCN

Registration Country : USA

blank

08

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2023-03-13

Application Number : 209738

Regulatory Info : DISCN

Registration Country : USA

blank

09

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2012-11-06

Application Number : 203214

Regulatory Info : RX

Registration Country : USA

blank

10

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2018-05-30

Application Number : 203214

Regulatory Info : RX

Registration Country : USA

blank

11

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ XR

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 11MG BASE

Packaging :

Approval Date : 2016-02-23

Application Number : 208246

Regulatory Info : RX

Registration Country : USA

blank

12

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ XR

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 22MG BASE

Packaging :

Approval Date : 2019-12-12

Application Number : 208246

Regulatory Info : RX

Registration Country : USA

blank

13

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ

Dosage Form : SOLUTION;ORAL

Dosage Strength : EQ 1MG BASE/ML

Packaging :

Approval Date : 2020-09-25

Application Number : 213082

Regulatory Info : RX

Registration Country : USA

blank

14

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

TOFACITINIB

Brand Name : TOFACITINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 209923

Regulatory Info :

Registration Country : USA

blank

15

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 11MG BASE

Packaging :

Approval Date : 2025-09-30

Application Number : 216001

Regulatory Info : RX

Registration Country : USA

blank

16

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Tofacitinib

Brand Name : Tofacitinib

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 215552

Regulatory Info :

Registration Country : USA

blank

17

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Tofacitinib

Brand Name : Tofacitinib

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 215552

Regulatory Info :

Registration Country : USA

blank

18

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2023-03-13

Application Number : 209829

Regulatory Info : DISCN

Registration Country : USA

blank

19

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 11MG BASE

Packaging :

Approval Date : 2021-08-19

Application Number : 214264

Regulatory Info : DISCN

Registration Country : USA

blank

20

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 22MG BASE

Packaging :

Approval Date : 2021-08-19

Application Number : 214264

Regulatory Info : DISCN

Registration Country : USA

blank